Identification of the cutoff value for serum alanine aminotransferase in hepatitis C screening of patients with chronic renal failure on hemodialysis;Identificação de ponto de corte no nível sérico da alanina aminotransferase para rastreamento da hepatite C em pacientes com insuficiência renal crônica em hemodiálise

Revista da Sociedade Brasileira de Medicina Tropical

Volumn 37, Issue 1, 2004, Pages 18-21

  Cavalcanti Gouveia, Ericson ^a   Lopes, Edmundo P A ^a,c   Moura, Izolda ^a   Cruz, Marluce ^b   Kosminsky, Letícia ^b   Pernambuco, J Ricardo ^a  

^a Federal University of Pernambuco   (Brazil)

^b Unidade de Dialise PRONTORIM   (Brazil)

^c Casa Forte   (Brazil)

Author keywords

Alanine aminotransferases; Anti HCV; Hemodialysis; Hepatitis C

Indexed keywords

ALANINE AMINOTRANSFERASE; HEPATITIS C ANTIBODY;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANTIBODY PRODUCTION; ARTICLE; CHRONIC KIDNEY FAILURE; FEMALE; HEMODIALYSIS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; MAJOR CLINICAL STUDY; MALE; NONHUMAN; NORMAL VALUE; RECEIVER OPERATING CHARACTERISTIC; SCREENING TEST; SENSITIVITY AND SPECIFICITY;

HEPATITIS C VIRUS; STAPHYLOCOCCUS PHAGE 187;

EID: 1442350410     PISSN: 00378682     EISSN: None     Source Type: Journal    
DOI: 10.1590/s0037-86822004000100005     Document Type: Article

References (26)

1. Al-Wakeel J, Malik GH, Al-Mohaya S, Mitwalli A, Baroudi F, El Gamal H, Kechrid M. Liver disease in dialysis patients with antibodies to hepatitis C virus. Nephrology Dialysis and Transplantation 11:2265-2268, 1996.
2. Carneiro MAS, Martins RMB, Teles SA, Silva SA, Lopes CL, Cardoso DDP, Wanderborght BOM, Yoshida CFT. Hepatitis C prevalence and risk factors in hemodialysis patients in Central Brazil: a survey by polymerase chain reaction and serological methods. Memórias do Instituto Oswaldo Cruz 96:765-769, 2001.
3. Conry-Cantilena C, Vanraden M, Gibble J, Melpolder J, Shakil AO, Viladomiu L, Cheung L, Di Bisceglie A, Hoofnagle J, Shih JW. Routes of infection, viremia, and liver disease in blood donors found to have hepatitis C virus infection. New England Journal of Medicine 334: 1734-1735, 1996.
4. Cotler SJ, Diaz G, Gundlapalli S, Jakate S, Chawla A, Mital D, Jensik S, Jensen DM. Characteristics of hepatitis C in renal transplant candidates. Journal of Clinical Gastroenterology 35: 191-195, 2002.
5. Fabrizi F, Lunghi G, Finazzi S, Colucci P, Pagano A, Ponticelli C, Locatelli F. Decreased serum aminotransferase activity in patients with chronic renal failure: impact on the detection of viral hepatitis. American Journal of Kidney Disease 38: 1009-1015, 2001.
6. Fabrizi F, Lunghi G, Pagliari B, Mangano S, Faranna P, Pagano A, Locatelli F. Molecular epidemiology of hepatitis C virus infection in dialysis patients. Nephron 77: 190-196, 1997.
7. Fabrizi F, Martin P, Dixit V, Brezina M, Cole M, Vinson S, Mousa M, Gitnick G. Biological dynamics of viral load in hemodialysis patients with hepatitis C virus. American Journal of Kidney Disease 35: 122-129, 2000.
8. Fabrizi F, Poordad FF, Martin P. Hepatitis C and the patient with end-stage renal disease. Hepatology 36:3-10, 2002.
9. Ferreira ASP. Análise comparativa das características bioquímicas e histológicas da infecção crônica pelo vírus da hepatite C entre portadores de insuficiência renal crônica terminal em diálise e indivíduos com função renal normal. Tese de Doutorado, Universidade Federal de São Paulo, São Paulo, SP, 2002.
10. Guh JY, Lai YH, Yang CY, Chen SC, Chuang WI., Hsu TC, Chen HC, Chang WY, Tsai JH. Impact of decreased serum transaminase levels on the evaluation of viral hepatitis in hemodialysis patients. Nephron 69:459-465, 1995.
11. Herrine SK, Michael B, Ma WL, Rossi S, Dunn SR, Hyslop T. Development of an HCV infection risk stratification algorithm for patients on chronic hemodialysis. American Journal of Gastroenterology 97:2619-2622, 2002.
12. Hinrichsen H, Leimenstoll G, Stegen G, Schrader H, Fölsch UR, Schmidt WE, PHV Study Group. Prevalence and risk factors of hepatitis C virus infection in hemodialysis patients: a multicentre study in 2796 patients. Gut 51:429-433, 2002.
13. Hung KY, Lee KC, Yen KD, Tsai TJ, Che WY. Revised cutoff values of serum aminotransferase in detecting viral hepatitis among CAPD patients: experience from Taiwan. an endemic area for hepatitis B. Nephrology Dialysis and Transplantation 12: 180-183, 1997.
14. Huraib S, Al-Rashed A, Aldress A, Aljefry M, Arif M, Al-Faleh A. High prevalence of and risk factors for HCV in hemodialysis patients in Saudi Arabia: A need for new dialysis strategies. Nephrology Dialysis and Transplantation 10:470-474, 1995.
15. Kleiner MJ, Tate SS, Sullivan JL, Chami J. Vitamin B6 deficiency in maintenance dialysis patients: metabolic effects of repletion. American Journal of Clinical Nutrion 33: 1612-1619, 1980.
16. Knudsen F, Wantzin P, Rasmussen K, Ladefoged SD, Lokkegaard N, Rasmussen LS, Lassen A, Krogsgaard K. Hepatitis in dialysis patients: Relationship to blood transfusions, dialysis and liver disease. Kidney International 43: 1353-1356, 1993.
17. McIntyre PG, McCruden EAB, Dow BC, Cameron SO, McMillan MA, Allison ME, Briggs JD. HCV infection in renal dialysis patients in Glasgow. Nephrology Dialysis and Transplantation 9:291-295, 1994.
18. Natov SN, Pereira BJG. Hepatitis C infection in patients on dialysis. Seminars in Dialysis 5:360-368, 1994.
19. Pol S, Romeo R, Zins B, Driss F, Lebkiri B, Carnot F, Berthelot P, Brechot C. Hepatitis C virus RNA in anti-HCV positive hemodialyzed patients: significance and therapeutic implications. Kidney International 44: 1097-1100, 1993.
20. Prati D, Taioli E, Zanalla A, Torre ED, Butell S, Vecchio ED, Vianello L, Zanuso F, Mozzi F, Milani S, Conte D, Colombo M, Sirchia G. Updated definitions of healthy ranges for serum alanine aminotransferase levels. Annals of internal Medicine 137: 1-9, 2002.
21. Rampino T, Arbustini E, Gregorini M, Guallini P, Libetta C, Maggio M, Ranghino A, Silini E, Soccio G, Dal Canton A. Hemodialysis prevents liver disease caused by hepatitis C virus: role of hepatocyte growth factor. Kidney International 56:2286-2291, 1999.
22. Roth C. Hepatitis C virus: the nephrologist's view. American Journal of Kidney Disease 25:3-16, 1995.
23. Santos JP, Loureiro A, Cendoroglo M, Pereira BJ. Impact of dialysis room and reuse strategies on the incidence of hepatitis C virus infection in haemodialysis units. Nephrology Dialysis and Transplantation 11:2017-2022, 1996.
24. Yasuda K, Okuda K, Endo N, Ishiwatari Y, Ikeda R, Hayashi H, Kobayashi S, Irie Y. Hypoaminotransferasemia in patients undergoing long-term hemodialysis: clinical and biochemical appraisal. Gastroenterology 109: 1295-1300, 1995.
25. Yuki N, Ishida H, Inoue T, Tabat T, Matsushita Y, Sasaki Y, Hayashi N, Hori M. Reappraisal of biochemical hepatitis C activity in hemodialysis patients. Journal of Clinical Gastroenterology 30: 187-194, 2000.
26. Zweig MH, Campbell G. Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine: Clinical Chemistry 39: 561-577, 1993.